Prof Dr Bindhu Gururajan is Senior Principal Scientist (Fellow) for Formulation and Process Development and a High Performance Pharmaceutical Development Formulation Project Leader in Novartis Pharma, Basel, Switzerland. He has done his Masters in Chemical Engineering from Indian Institute of Technology Delhi and PhD in Chemical Engineering from The University of Birmingham, U.K. Later did his Post-Doctoral research in Pharmaceutical Sciences with University of Greenwich, U.K. based in Pfizer Research Center, Sandwich site on granulation process scale up and modelling. He is an Internationally recognised Pharmaceutical Granulation Expert. He has two decades of hands on practical experience in drug development and delivery by working for four major pharmaceutical company namely Merck, Pfizer, AstraZeneca and Novartis in his career. He is active senior committee member of the Particle Technology Subject Group of Institute of Chemical Engineers (IChemE). He is certified Chartered Engineer and Chartered Scientist. Fellow of Royal Society of Chemistry, Institute of Chemical Engineers and Academy of Pharmaceutical Sciences. Master Black Belt in Lean Six Sigma for quality management system.
He holds several patents for inflammation and oncology (cancer) drug product formulations and widely published in the granulation process research area. He developed the formulation and manufacturing process for two recent breast cancer product Kisqali and Piqray to improve patients life. He is currently work on late phase oncology project in particular formulation and process development by applying Chemical Engineering first principles approach.
2000 - 2004: PhD Chemical Engineering, The University of Birmingham, U.K.
1998 - 2000: MS (by Research) Chemical Engineering, Indian Institute of Technology Delhi, India
1994 - 1998: B.Tech Chemical Engineering, Sri Venkateswara College of Engineering, University of Madras, India
Professional Qualifications and Memberships:
Memberships: CEng, CSci, FIChemE, FRSC, FAPS
Formulation, Process Modelling and Pharmaceutical Development